Fludeoxyglucose F 18
NDC 76318-334, Fludeoxyglucose F-18, injection, solution, from Massachusetts General Hospital.
- Product NDC
- 76318-334
- Status
- Listed
- Labeler
- Massachusetts General Hospital
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204333
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/76318-334 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FLUDEOXYGLUCOSE F-18300 mCi/mL
Pharmacologic classes
Radioactive Diagnostic Agent [EPC]; Radiopharmaceutical Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 76318-334-50 | 76318033450 | 50 mL in 1 VIAL (76318-334-50) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/232fbb91-402e-44d8-a0cf-6813980b8ead
Use it
Look up 76318-334 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/76318-334 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 76318-334. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.